Clinical Trial Update: 9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy of Ofatumumab on microglial activity in patients with Relapsing Multiple Sclerosis has completed and posted results. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2026-01-27